Cite
Pal G, Mangone G, Hill EJ, et al. Parkinson disease and STN-DBS: cognitive effects in GBA mutation carriers. Ann Neurol. 2022;doi: 10.1002/ana.26302.
Pal, G., Mangone, G., Hill, E. J., Ouyang, B., Liu, Y., Lythe, V., Ehrlich, D., Saunders-Pullman, R., Shanker, V., Bressman, S., Alcalay, R. N., Garcia, P., Marder, K. S., Aasly, J., Mouradian, M. M., Link, S., Rosenbaum, M., Anderson, S., Bernard, B., Wilson, R., Stebbins, G., Nichols, W. C., Welter, M. L., Sani, S., Afshari, M., Verhagen, L., de Bie, R. M. A., Foltynie, T., Hall, D., Corvol, J. C., & Goetz, C. G. (2022). Parkinson disease and STN-DBS: cognitive effects in GBA mutation carriers. Annals of neurology, . https://doi.org/10.1002/ana.26302
Pal, Gian, et al. "Parkinson disease and STN-DBS: cognitive effects in GBA mutation carriers." Annals of neurology vol. (2022). doi: https://doi.org/10.1002/ana.26302
Pal G, Mangone G, Hill EJ, Ouyang B, Liu Y, Lythe V, Ehrlich D, Saunders-Pullman R, Shanker V, Bressman S, Alcalay RN, Garcia P, Marder KS, Aasly J, Mouradian MM, Link S, Rosenbaum M, Anderson S, Bernard B, Wilson R, Stebbins G, Nichols WC, Welter ML, Sani S, Afshari M, Verhagen L, de Bie RMA, Foltynie T, Hall D, Corvol JC, Goetz CG. Parkinson disease and STN-DBS: cognitive effects in GBA mutation carriers. Ann Neurol. 2022 Jan 04; doi: 10.1002/ana.26302. Epub 2022 Jan 04. PMID: 34984729.
Copy
Download .nbib